The Clinical Research Of Treating Acute Cerebral Infarction And Control Of Associate Risk Factors By Xingnaojing Injection

Objective:To observe the clinical effect of Xingnaojing injection on treating acute cerebral infarction and control of associate risk factors.Method:Selected 68 patients of tested conditions in the Second Affiliated Hospital of GuangXi University of Chinese Medicine in this study.Assign them with the method of simple random into treatment group and control group.The treatment group was treated with Xingnaojing injection Treatment on the basis of conventional treatment of Western Medicine(0.9% sodium chloride injection 250 ml or 5% glucose injection 250 ml plus Xingnaojing Injection 20 ml,intravenous drip,once a day).The control group was treated on the basis of conventional treatment of Western Medicine.The total course of treatment was 14 days.Use the changes of the score of syndrome in TCM,hemorheology,blood fat and NIHSS to compare the clinical effect of two groups,in order to evaluate the curative effect and control of associate risk factors of Xingnaojing injection in the treatment of acute cerebral infarction.Results:1.The clinical observation on 68 cases of acute cerebral infarction patients indicates that,the NIHSS scores of both groups before and aftertreatment are different.The difference is statistically significant(P<0.05).The total effective rate in treatment group is 94.18%,while the rate in control group is 79.41%.Comparing the total efficiency of these two groups,the difference was statistically significant(P<0.05),which indicates that compared with the total effect of basis of conventional treatment of Western Medicine.The scores of syndrome in TCM of treatment group before and after treatment are different.The difference is statistically significant(P<0.05).Xingnaojing injection in the treatment of acute cerebral infarction has the better clinical effect.2.In the TCM syndrome of “stirring wind due to yin deficiency” and“qi deficiency and blood stasis” cases,comparing the efficacy of syndrome in TCM in the two groups before and after treatment,the difference was not statistically significant(P>0.05).3.In the TCM syndrome of “excessive fu-viscera caused by phlegm-heat” and “blockade of wind-phlegm-static blood” cases,comparing the efficacy of syndrome in TCM in the two groups before and after treatment,the difference was statistically significant(P<0.05).The treatment group curative effect is better than that of control group.4.The improvement of hemorheology targets and blood fat are both lower then before treatment in two groups,the difference was statistically significant(P<0.05).The treatment group curative effect is better than that of control group.The difference was statistically significant(P<0.05).Conclusion:Xingnaojing injection in the treatment of acute cerebral infarction is effective.The total efficiency compared with the control group has significant difference.In the TCM syndrome of "stirring wind due to yin deficiency,qi deficiency and blood stasis" cases,the observation group and the control group has no difference in the efficacy.In the TCM syndrome typing of "excessive fu-viscera caused by phlegm-heat,blockade of wind-phlegm-static blood" cases,the curative effect of Xingnaojing injection is better than basis of conventional treatment of Western Medicine.The improvement of hemorheology targets and blood fat are lower then before treatment in two groups and the treatment group curative effect is better than that of control group.Which means an important work in the control of associate risk factors.